GlassScriptPhysician profile
Youjin Walsh
NPI 1447038252
$1,476.65
in general payments reported to CMS, 2019-2025
13 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $203 · 2024: $1,108 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,476.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $516.58 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $302.71 | 2023-2025 | |
| Radius Health, INC. | $199.73 | 2023-2024 | Tymlos |
| Abiomed | $145.15 | 2025 | |
| Corcept Therapeutics | $65.47 | 2024 | Korlym |
| Novo Nordisk INC | $58.36 | 2024 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $46.94 | 2024 | |
| Astellas Pharma US INC | $35.75 | 2024 | Veozah |
| Exact Sciences Corporation | $33.01 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $18.98 | 2024 | Evenity, Prolia |
| Ardelyx, INC. | $18.25 | 2024 | Ibsrela |
| Glaxosmithkline, LLC. | $18.05 | 2024 | Shingrix |
| Corium, LLC | $17.67 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Youjin Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.